Cantel Medical Corp. (NYSE:CMN), Little Falls, N.J., reported
income from continuing operations of $2,157,000, or $0.13 per diluted
share (inclusive of approximately $0.02 of stock-based compensation
expense), on an 18% increase in sales to $60,910,000 for the second
quarter ended January 31, 2008. This compares with income from
continuing operations of $2,252,000, or $0.14 per diluted share
(inclusive of approximately $0.01 of stock-based compensation expense),
on sales of $51,635,000 for the second quarter ended January 31, 2007.
For the six months ended January 31, 2008, the company reported income
from continuing operations of $4,096,000, or $0.25 per diluted share
(inclusive of $0.04 of stock-based compensation expense), on an 18%
increase in sales to $120,915,000. This compares with income from
continuing operations of $3,975,000, or $0.25 per diluted share
(inclusive of $0.02 of stock-based compensation expense), on sales of
$102,119,000 for the six months ended January 31, 2007. According to R.
Scott Jones, Cantel's president and CEO, "We were pleased with
our continued core revenue growth in the second quarter, as well as the
first half of 2008. Our growth in earnings from an EBITDAS1 perspective
was 15% (to $8,223,000) for the quarter and 19% (to $16,069,000) for the
first half of the year, compared to the same periods last year. We have
made significant investments in marketing and sales during the past six
months, as well as in recent acquisitions, and anticipate realizing the
benefits from these initiatives in the coming quarters.
The company further reported that its balance sheet at January 31,
2008 included current assets of $83,609,000, including cash of
$14,208,000, a current ratio of 2.6:1, a ratio of funded debt to equity
of .41:1, debt of $66,800,000 and stockholders' equity of
$163,784,000.
Cantel Medical Corp. is a leading provider of infection prevention
and control products in the healthcare market. Our products include
specialized medical device reprocessing systems for renal dialysis and
endoscopy, dialysate concentrates and other dialysis supplies,
disposable infection control products primarily for the dental industry,
water purification equipment, sterilants, disinfectants and cleaners,
hollow fiber membrane filtration and separation products for medical and
non-medical applications, and specialty packaging for infectious and
biological specimens. We also provide technical maintenance for our
products and offer compliance training services for the transport of
infectious and biological specimens.
For more information, visit http://www.cantelmedical.com or call
973/890-7220.
COPYRIGHT 2008 Worldwide
Videotex Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.